An LLNL team 3D printed live yeast cells on lattices.
Lawrence Livermore National Laboratory (LLNL) researchers have 3D printed live cells that convert glucose to ethanol and carbon dioxide gas (CO2), a substance that resembles beer, demonstrating a technology that can lead to high biocatalytic efficiency.
Bioprinting living mammalian cells into complex 3D scaffolds has been widely studied and demonstrated for applications ranging from tissue regeneration to drug discovery to clinical implementation. In addition to mammalian cells, there is a growing interest in printing functional microbes as biocatalysts.
Microbes are extensively used in industry to convert carbon sources into valuable end-product chemicals that have applications in the food industry, biofuel production, waste treatment and bioremediation. Using live microbes instead of inorganic catalysts has advantages of mild reaction conditions, self-regeneration, low cost and catalytic speci?city.
The new research, which appears as an ACS Editors’ Choice article in the journal Nano Letters, shows that the additive manufacturing of live whole-cells can assist in research in microbial behaviors, communication, interaction with the microenvironment and for new bioreactors with high volumetric productivity.
In a case study, the team printed freeze-dried live biocatalytic yeast cells (Saccharomyces cerevisiae) into porous 3D structures. The unique engineered geometries allowed the cells to convert glucose to ethanol and CO2 very efficiently and similar to how yeast on its own can be used to make beer. Enabled by this new bio-ink material, the printed structures are self-supporting, with high resolution, tunable cell densities, large scale, high catalytic activity and long-term viability. More importantly, if genetically modified yeast cells are used, high-valuable pharmaceuticals, chemicals, food and biofuels can be produced as well.
“Compared to bulk film counterparts, printed lattices with thin filament and macro-pores allowed us to achieve rapid mass-transfer leading to several-fold increase in ethanol production,” said LLNL materials scientist Fang Qian, the lead and corresponding author on the paper. “Our ink system can be applied to a variety of other catalytic microbes to address broad application needs. The bioprinted 3D geometries developed in this work could serve as a versatile platform for process intensi?cation of an array of bioconversion processes using diverse microbial biocatalysts for production of high-value products or bioremediation applications.”
Other Livermore researchers include Cheng Zhu, Jennifer Knipe, Samantha Ruelas, Joshua Stolaroff, Joshua DeOtte, Eric Duoss, Christopher Spadaccini and Sarah Baker. This work was conducted in collaboration with National Renewable Energy Laboratory.
“There are several benefits to immobilizing biocatalysts, including allowing continuous conversion processes and simplifying product purification,” said chemist Baker, the other corresponding author on the paper. “This technology gives control over cell density, placement and structure in a living material. The ability to tune these properties can be used to improve production rates and yields. Furthermore, materials containing such high cell densities may take on new, unexplored beneficial properties because the cells comprise a large fraction of the materials.”
“This is the first demonstration for 3D printing immobilized live cells to create chemical reactors,” said engineer Duoss, a co-author on the paper. “This approach promises to make ethanol production faster, cheaper, cleaner and more efficient. Now we are extending the concept by exploring other reactions, including combining printed microbes with more traditional chemical reactors to create ‘hybrid’ or ‘tandem’ systems that unlock new possibilities.”
Learn more: 3D-printed live cells convert glucose to ethanol, carbon dioxide to enhance catalytic efficiency
The Latest on: Biocatalysts
via Google News
The Latest on: Biocatalysts
- Biomedical Applications of Transition Metal Dichalcogenide Nanozymeson January 7, 2022 at 4:30 pm
Nanozymes (NZs), a family of nanoparticles with enzyme-like characteristics and functionalities, have been explored for a broad variety of healthcare systems and are prospective substitutes for ...
- Researchers develop a method that gives enzymes the ability to catalyze new-to-nature reactionson January 6, 2022 at 12:56 pm
"If we can develop these so-called new-to-nature enzymatic activities, then we have very powerful biocatalysts for pharmaceutical and agrochemical industries," said Yang, who with colleagues at UC ...
- Versatility and Selectivityon January 6, 2022 at 10:06 am
“If we can develop these so-called new-to-nature enzymatic activities, then we have very powerful biocatalysts for pharmaceutical and agrochemical industries,” said Yang, who with colleagues at UC ...
- Medical Biocatalysts Market , Indutry Analysis and Prospect, Market Players : Royal DSM N.V., Codexis, BASF SE - 2022 - 2027on January 5, 2022 at 4:00 pm
Jan 06, 2022 (Heraldkeepers) -- The "Medical Biocatalysts" Market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth ...
- Global Animals Source Specialty Enzymes Market Size, Share and Forecast 2021-2027on December 29, 2021 at 2:00 am
Enzymes are generally the biocatalysts that are specific for accelerating various types of chemical reactions without undergoing self-changes. These enzymes have distinct clinical applications and ...
- Global Enzymes Market 2021 Trending Technologies, Developments, Key Players and Forecast to 2021- 2027on December 24, 2021 at 5:16 pm
In addition, enzymes are biocatalysts that alternate the response rate and bring the desired effects in organic reactions. They are similar to in nature and have amassed a unique attention in ...
- Covid-19 Impact on Biocatalysis & Biocatalysts Market to Show Incredible Growth by 2027 | BASF, Codexison December 22, 2021 at 9:05 am
Another exploration Titled "Worldwide Biocatalysis & Biocatalysts 2019-Market Research Report" gives the Professional and inside and out assessment of extent of momentum and future market and ...
- DNAzymes – how active DNA molecules with therapeutic potential workon December 21, 2021 at 4:00 pm
DNAzymes are precision biocatalysts that destroy unwanted RNA molecules. However, major obstacles to their use in medicine remain. Scientists have investigated with atomic resolution how DNAzymes ...
- Winner: 2021 Chemistry Biology Interface Division Horizon Prize:on June 8, 2021 at 2:50 am
These medicines must also be produced in highly pure form for use in patients. One such approach employs enzymes or biocatalysts which are safe, highly selective and produce minimal waste. The ...
- David H Kwan, PhDon February 8, 2021 at 9:46 pm
Enzymes are extraordinary biocatalysts –they are the machinery within cell factories crafted by Nature over aeons of evolution. The aims of my research are focused upon using techniques in synthetic ...
via Bing News
